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We describe two cases where patients undergoing hepatic resection for metastatic disease of colorectal origin were found to have
concomitant sclerosing haemangiomas. The typical radiological and histological appearances of these lesions are discussed.
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1. Introduction
Haemangiomas constitute the largest group of noncystic liver
lesions [1], as a result they frequently present as confounding
lesions when staging and investigating intra-abdominal
malignancies. The sclerosed variant of liver haemangiomas
is considerably less common. This describes two patients
with metastatic colorectal malignancy in whom sclerosed
haemangiomas were also identified.
2. Case 1
The first patient, a 72-year-old male, presented with large
bowel obstruction secondary to a rectal cancer which was
treated with a defunctioning colostomy and adjuvant
chemoradiotherapy. Having completed the course
of chemotherapy a staging CT was performed which
demonstrated an ill-defined low density lesion in segment
4a. Dynamically this had enlarged from a CT scan 2 months
previously. There was mild contrast enhancement of the
lesion between arterial and venous phases with an increase
of approx 5HU in density between the two phases. Another
lesion was noted in segment 7, again low density, but stable
in size when compared to the previous study. This showed
less enhancement when compared to the lesion in 4a. Both
these lesions were thought to be consistent with metastatic
deposits.
The patient underwent a routine ultra-low anterior
resection with covering loop ileostomy. It was noted at
the time of the laparotomy that there was a palpable
metastasis adjacent to the falciform ligament. Further
imaging for planning of the liver resection showed both
lesions to have enlarged in size although the lesion in
segment VII showed a smaller increase and was indeter-
minate in nature. At operation two surface liver lesions
were seen and wedge excision was performed. The his-
tology revealed a metastatic deposit of adenocarcinoma
within segment 4a whilst segment VII showed a sclerosed
haemangioma.
3. Case 2
The second patient, an 84-year-old male, had previously
undergone a right hemicolectomy for adenocarcinoma and
was noted at the time of the resection to have hepatic
metastases. Having received chemotherapy postoperatively
he was restaged to assess the feasibility of hepatic resection.
The CT demonstrated four lesions in total, with sub
centimetre hypodense lesions in segments 2 and 5, and
larger lesions in segments 4b and 6 (Figure 2). The two
larger lesions were thought to be consistent with malignant
disease whilst the smaller segment 2 lesion was indeterminate
and the abnormality in segment 5 was in keeping with a
simple cyst. At laparotomy the lesions were further evaluated
with intraoperative ultrasound. This confirmed the lesions
in segments 2 and 5 to be cystic in nature and the patient
therefore proceeded to a partial right hepatectomy without
incident. Upon histological sectioning of the specimen only
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one metastatic deposit was found in segment 6, with the
segment 4b lesion being a sclerosing haemangioma.
4. Discussion
These cases highlight the diﬃculty in diﬀerentiating between
benign and malignant diseases in staging colorectal hepatic
metastases. Furthermore we demonstrate the occurrence of
rare hepatic lesions in mimicking malignant disease. Some
authorities consider haemangiomas to be benign congenital
hamartomas. They are composed of masses of blood vessels
that are atypical or irregular in arrangement and size. Aeti-
ology remains unknown with no definite familial or genetic
mode of inheritance being described. When fibrosis occurs
in an existing haemangioma then it may progress to the
sclerosed variant. It is diﬃcult to ascertain the precipitating
event for this to occur. There are numerous reports of
haemangiomas rupturing spontaneously or in association
with trauma. It would therefore seem plausible that minor
haemorrhage and thrombosis within a haemangioma may
instigate fibrotic progression to a sclerosed haemangioma.
Makhlouf et al. suggested that mast cells play a pivotal role
in the development of a sclerosed haemangioma, perhaps
representing a distinct histological subtype of liver lesion
[2].
Not all haemangiomas remain stable in size or display
typical appearances on imaging (due to the development of
fibrous change) and this may lead to diﬃculty in accurately
predicting the true nature of these incidental lesions when
they occur. CT features suggestive of sclerosed haeman-
giomas include geographic outline, capsular retraction,
decrease in size over time, and loss of previously seen regions
of enhancement. Additional features include the presence of
transient hepatic attenuation diﬀerence, rim enhancement,
and nodular regions of intense enhancement as seen in
typical haemangiomas [3]. Alternate imaging modalities
such as MRI should be considered for further evaluation of
indeterminate lesions. Radiological appearances must also be
correlated to the treatment regimen specific to the patient.
Adjuvant chemotherapy may lead to the change of a lesion
on serial imaging, adding further weight to a diagnosis of
malignancy.
The common histological appearances of sclerosed hae-
mangiomas consist of multiple thin walled vessels within
a hypocellular stroma demonstrating varying degrees of
fibrosis and sclerosis (Figure 1). Macroscopically a haeman-
gioma is usually reddish-blue and well demarcated from
surrounding tissue. However the sclerosed variant is seen as
a pale nodule if there is significant fibrosis present. The cell
type of origin is mesenchymal and as such the lesions can
occur almost anywhere [4].
Whilst the prevalence of haemangioma has been reported
as high as 20% when found incidentally at autopsy [5], the
sclerosed variant is considered much rarer. Sclerosis may
occur at varying degrees to mask the appearance of the
haemangioma. When complete the lesion takes on a much
more fibrotic appearance exhibiting few of the characteristics
of the lesion from which it originated. In patients whom
have metastatic liver lesions any indeterminate lesion must
Figure 1: Sclerosed haemangioma with feeding vessel.
Figure 2: CT Scan showing segment 4b sclerosing haemangioma.
be treated with extreme caution to ensure that there is no
residual disease.
One of the key questions in the management of patients
in this scenario is whether to biopsy the lesion in question at
the time of the operation or to proceed straight to formal
resection. Whilst thorough preoperative investigation will
guide the surgeon in their management, this decision can
only be made at the time of operation. We would certainly
not condone preoperative biopsy of any liver lesions in
the context of planning definitive treatment for suspected
colorectal hepatic metastases. However, it is conceivable
that if excision of an indeterminate lesion may significantly
increase the length or risk of surgery (especially in high-
risk patients) then an intraoperative biopsy with frozen
histology could be considered. Patients should always be
informed of the potential for benign pathology when surgery
is recommended for indeterminate lesions. Hepatic resection
for benign conditions is only indicated where there are
persistent symptoms, uncertainty regarding the diagnosis
or the risk of malignant transformation [6]. However a
systematic review failed to demonstrate any significant
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evidence to support the elective resection of benign liver
tumours, although the number of patients was limited and
no randomised control trial data is available [7].
Cross-sectional imaging, whilst continually improving
in detail, can still not always diﬀerentiate between certain
benign lesions and malignant disease. This is particularly
true for small lesions less than 5mm. In the context of
multiple mixed lesions tumour makers will not help quantify
or localise metastatic deposits. Whilst a PET scan may help
distinguish between benign and malignant disease there
are still instances where benign pathologies can mimic
malignancy.
5. Conclusion
In both cases the clinical index of suspicion for metastatic
spread was high given the advanced nature of the colorectal
cancers. Despite accurate preoperative investigation it may
not always be possible to delineate between a benign lesion
such as a sclerosing haemangioma and a true metastatic
deposit, especially when the two coexist. The typical imaging
features of sclerosed haemangioma have recently been pub-
lished as discussed earlier. However no imaging technique
can be 100% accurate. Tumour markers will not diﬀerentiate
between the two pathologies in this scenario whilst both
false positives and negatives can occur with PET scans [8].
If a lesion is not readily resectable, an intraoperative biopsy
can provide a tissue diagnosis to negate the risk of a major
resection. When there is persistent doubt regarding the
diagnosis it would seem prudent to plan for resection of the
lesion with the patient prepared for the eventuality of benign
pathology. Given the relatively common occurrence of
haemangiomas combined with a high incidence of colorectal
cancer, cases such as these may become a more common
event.
References
[1] J. P. Arnoletti and J. Brodsky, “Surgical treatment of benign
hepatic mass lesions,” The American Surgeon, vol. 65, no. 5, pp.
413–433, 1999.
[2] H. R. Makhlouf and K. G. Ishak, “Sclerosed hemangioma and
sclerosing cavernous hemangioma of the liver: a compara-
tive clinicopathologic and immunohistochemical study with
emphasis on the role of mast cells in their histogenesis,” Liver,
vol. 22, no. 1, pp. 70–78, 2002.
[3] D. J. Doyle, K. Khalili, M. Guindi, et al., “Imaging features
of sclerosed hemangioma,” American Journal of Roentgenology,
vol. 189, pp. 67–72, 2007.
[4] F. C. Nichols, J. A. van Heerden, and L. H. Weiland, “Benign
liver tumours,” Surgical Clinics of North America, vol. 69, pp.
297–314, 1989.
[5] P. J. Karhunen, “Benign hepatic tumours and tumour like
conditions in men,” Journal of Clinical Pathology, vol. 39, no.
2, pp. 183–188, 1986.
[6] D. Clarke, E. Currie, K. Madhavan, R. Parks, and O. Garden,
“Hepatic resection for benign non-cystic liver lesions,” Holiday
Property Bond, vol. 6, no. 2, pp. 115–119, 2004.
[7] A. Colli, M. Fraquelli, S. Massironi, A. Colucci, S. Paggi, and
D. Conte, “Elective surgery for benign liver tumours,” Cochrane
Database of Systematic Reviews, vol. 24, no. 1, Article ID
CD005164, 2007.
[8] J. M. Chang, H. J. Lee, J. M. Goo, et al., “False positive and false
negative FDG-PET scans in various thoracic diseases,” Korean
Journal of Radiology, vol. 7, no. 1, pp. 57–69, 2006.
